Kymera Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	357.01	120.26	109.97	68.4	47.98
Short-Term Investments	491.27	368.49	264.92	338.77	394.44
Cash & Short-Term Investments	848.28	488.74	374.88	407.17	442.42
Cash Growth	73.56%	30.37%	-7.93%	-7.97%	49.36%
Accounts Receivable	-	-	15	-	-
Other Receivables	-	-	3.76	2.54	0.14
Total Trade Receivables	-	-	18.76	2.54	0.14
Other Current Assets	22.94	21.52	11.67	9.71	8.72
Total Current Assets	871.21	510.27	405.32	419.42	451.27
Net Property, Plant & Equipment	85.53	97.86	101.08	22.24	21.31
Long-Term Investments	771.16	362.16	61.43	152.33	125.19
Other Long-Term Assets	14.91	7.74	7.93	9.15	8.14
Total Assets	1,743	978.04	575.76	603.13	605.91
Accounts Payable	4.02	5.99	7.08	4.34	4.01
Accrued Expenses	42.27	34.87	33.86	27.5	22.97
Current Portion of Leases	13.76	13.11	6.35	3.94	3.6
Unearned Revenue	22.93	13.58	37.88	35.26	61.74
Other Current Liabilities	0.24	0.22	0.52	0.3	0.23
Total Current Liabilities	83.21	67.77	85.69	71.34	92.54
Long-Term Leases	68.5	74.65	78.33	13.39	14.36
Other Long-Term Liabilities	11.44	-	16.77	28.25	39.36
Total Long-Term Liabilities	79.94	74.65	95.1	41.64	53.73
Total Liabilities	163.15	142.42	180.79	112.98	146.27
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	2,644	1,592	926.27	878.88	689.28
Accumulated Other Comprehensive Income	1.8	-1.49	-0.55	-4.95	-0.66
Retained Earnings	-1,066	-754.61	-530.75	-383.79	-228.98
Shareholders' Equity	1,580	835.62	394.97	490.15	459.64
Total Liabilities & Equity	1,743	978.04	575.76	603.13	605.91
Total Debt	82.25	87.76	84.67	17.34	17.96
Net Cash (Debt)	766.02	400.98	290.21	389.83	424.46
Net Cash Growth	91.04%	38.17%	-25.56%	-8.16%	52.57%
Net Cash Per Share	9.07	5.34	4.97	7.23	8.85
Book Value	1,580	835.62	394.97	490.15	459.64
Book Value Per Share	18.70	11.14	6.77	9.09	9.58
Tangible Book Value	1,580	835.62	394.97	490.15	459.64
Tangible Book Value Per Share	18.70	11.14	6.77	9.09	9.58

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q